Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,882
archived clinical trials in
Obesity Weight Loss

Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
2020
mi
from 98109
Cleveland, OH
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
2020
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
2004
mi
from 98109
Columbus, OH
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
2004
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
2048
mi
from 98109
Mogadore, OH
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
2048
mi
from 98109
Mogadore, OH
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
1511
mi
from 98109
Yukon, OK
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
1511
mi
from 98109
Yukon, OK
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
2378
mi
from 98109
Bensalem, PA
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
2378
mi
from 98109
Bensalem, PA
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
2485
mi
from 98109
Cranston, RI
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
2485
mi
from 98109
Cranston, RI
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
2227
mi
from 98109
Greenville, SC
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
2227
mi
from 98109
Greenville, SC
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
2424
mi
from 98109
Mount Pleasant, SC
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
2424
mi
from 98109
Mount Pleasant, SC
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
2168
mi
from 98109
Bristol, TN
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
2168
mi
from 98109
Bristol, TN
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
1951
mi
from 98109
Burns, TN
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
1951
mi
from 98109
Burns, TN
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
2113
mi
from 98109
Knoxville, TN
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
2113
mi
from 98109
Knoxville, TN
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
1970
mi
from 98109
Nashville, TN
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
1970
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
1890
mi
from 98109
Houston, TX
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
1677
mi
from 98109
Jackson, TX
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
1677
mi
from 98109
Jackson, TX
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
1786
mi
from 98109
New Braunfels, TX
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
1786
mi
from 98109
New Braunfels, TX
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
1790
mi
from 98109
San Antonio, TX
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
1790
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
707
mi
from 98109
West Jordan, UT
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
707
mi
from 98109
West Jordan, UT
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
2348
mi
from 98109
Richmond, VA
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
2348
mi
from 98109
Richmond, VA
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
28
mi
from 98109
Renton, WA
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
28
mi
from 98109
Renton, WA
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
1646
mi
from 98109
Green Bay, WI
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
1646
mi
from 98109
Green Bay, WI
Click here to add this to my saved trials
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
1681
mi
from 98109
Wauwatosa, WI
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Open-Label Extension (OLE) Safety and Efficacy Study of Velneperit (S-2367) Following the Year-Long Controlled Clinical Trials of S-2367 in Obese Males and Females
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
1681
mi
from 98109
Wauwatosa, WI
Click here to add this to my saved trials
Progressive Metabolic Adaptations to Low Intensity Exercise Training and Weight Loss
Status: Enrolling
Updated:  4/30/2018
Michigan Clincal Research Unit
1901
mi
from 98109
Ann Arbor, MI
Progressive Metabolic Adaptations to Low Intensity Exercise Training and Weight Loss
Status: Enrolling
Updated: 4/30/2018
Michigan Clincal Research Unit
1901
mi
from 98109
Ann Arbor, MI
Click here to add this to my saved trials
A Randomized Trial of Recommendations for Exercise to Prevent Weight Regain
A Randomized Trial of Recommendations for Exercise to Prevent Weight Regain
Status: Enrolling
Updated:  4/30/2018
University of Kansas - Robinson Hall
1478
mi
from 98109
Lawrence, KA
A Randomized Trial of Recommendations for Exercise to Prevent Weight Regain
A Randomized Trial of Recommendations for Exercise to Prevent Weight Regain
Status: Enrolling
Updated: 4/30/2018
University of Kansas - Robinson Hall
1478
mi
from 98109
Lawrence, KA
Click here to add this to my saved trials
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
Status: Enrolling
Updated:  4/30/2018
University of Minnesota, School of Nursing
1391
mi
from 98109
Minneapolis, MN
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
Status: Enrolling
Updated: 4/30/2018
University of Minnesota, School of Nursing
1391
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
Status: Enrolling
Updated:  4/30/2018
University of Massachusetts Amherst
2417
mi
from 98109
Amherst, MA
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
Status: Enrolling
Updated: 4/30/2018
University of Massachusetts Amherst
2417
mi
from 98109
Amherst, MA
Click here to add this to my saved trials
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
Status: Enrolling
Updated:  4/30/2018
Temple University
2372
mi
from 98109
Philadelphia, PA
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
School Nurse-directed Secondary Obesity Prevention for Elementary School Children
Status: Enrolling
Updated: 4/30/2018
Temple University
2372
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Partnerships to Improve Lifestyle Interventions (PILI) 'Ohana Dissemination Project
Status: Enrolling
Updated:  4/30/2018
Department of Native Hawaiian Health, University of Hawaii
2679
mi
from 98109
Honolulu, HI
Partnerships to Improve Lifestyle Interventions (PILI) 'Ohana Dissemination Project
Status: Enrolling
Updated: 4/30/2018
Department of Native Hawaiian Health, University of Hawaii
2679
mi
from 98109
Honolulu, HI
Click here to add this to my saved trials
Promoting Healthier Food Purchases By Leveraging the Online-Grocery Environment
Promoting Healthier Food Purchases By Leveraging the Online-Grocery Environment
Status: Enrolling
Updated:  4/30/2018
University of Vermont
2326
mi
from 98109
Burlington, VT
Promoting Healthier Food Purchases By Leveraging the Online-Grocery Environment
Promoting Healthier Food Purchases By Leveraging the Online-Grocery Environment
Status: Enrolling
Updated: 4/30/2018
University of Vermont
2326
mi
from 98109
Burlington, VT
Click here to add this to my saved trials
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of BFKB8488A in Otherwise Healthy Overweight and Obese Participants With Likely Insulin Resistance
A Phase Ia, Randomized, Blinded, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Intravenous BFKB8488A in Otherwise Healthy Overweight and Obese Volunteers With Likely Insulin Resistance
Status: Enrolling
Updated:  4/30/2018
Profil Institute for Clinical Research
1074
mi
from 98109
Chula Vista, CA
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of BFKB8488A in Otherwise Healthy Overweight and Obese Participants With Likely Insulin Resistance
A Phase Ia, Randomized, Blinded, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Intravenous BFKB8488A in Otherwise Healthy Overweight and Obese Volunteers With Likely Insulin Resistance
Status: Enrolling
Updated: 4/30/2018
Profil Institute for Clinical Research
1074
mi
from 98109
Chula Vista, CA
Click here to add this to my saved trials
Resistance Exercise and Muscle Protein Synthesis in Obese Adults
Resistance Exercise as a Strategy to Enhance Postprandial Muscle Protein Synthesis in Obese Adults
Status: Enrolling
Updated:  4/30/2018
Freer Hall
1761
mi
from 98109
Urbana, IL
Resistance Exercise and Muscle Protein Synthesis in Obese Adults
Resistance Exercise as a Strategy to Enhance Postprandial Muscle Protein Synthesis in Obese Adults
Status: Enrolling
Updated: 4/30/2018
Freer Hall
1761
mi
from 98109
Urbana, IL
Click here to add this to my saved trials
Time Restricted Feeding for Weight Loss and Cardio-protection
Time Restricted Feeding for Weight Loss and Cardio-protection
Status: Enrolling
Updated:  4/30/2018
University of Illinois at Chicago
1733
mi
from 98109
Chicago, IL
Time Restricted Feeding for Weight Loss and Cardio-protection
Time Restricted Feeding for Weight Loss and Cardio-protection
Status: Enrolling
Updated: 4/30/2018
University of Illinois at Chicago
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Omega-3 Supplementation Decreases Inflammation and Fetal Obesity in Pregnancy
Omega-3 Supplementation Decreases Inflammation and Fetal Obesity in Pregnancy
Status: Enrolling
Updated:  5/1/2018
MetroHealth Med Ctr
2020
mi
from 98109
Cleveland, OH
Omega-3 Supplementation Decreases Inflammation and Fetal Obesity in Pregnancy
Omega-3 Supplementation Decreases Inflammation and Fetal Obesity in Pregnancy
Status: Enrolling
Updated: 5/1/2018
MetroHealth Med Ctr
2020
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials